Grandway November 20th | Jiuyuan Genetics (2566.HK) will be listed for subscription today until next Monday (25th), with a subscription price of HK$11.48-12.56 per share, offering 45.3988 million shares, with 10% for public offering in Hong Kong and the rest for international placement, raising up to HK$0.57 billion. 200 shares per board lot, with an entrance fee of HK$2537.33. The stock is expected to be listed next Thursday (28th). The company has introduced 7 cornerstone investors, including Fosun Pharma's subsidiary Fosun Industrial, ali health's ali health Hong Kong, with a total subscription amount of approximately HK$0.35 billion. Around 40% of the funds raised by the company will be allocated to the continuous research and development of selected investigational products in its strategically focused therapeutic areas; around 30% will be used for the marketing and commercialization of existing and near-commercial products; around 10% will be used for seeking strategic partnerships; around 10% will be used for its manufacturing system to build new production lines, upgrade, and further automate existing production facilities; around 10% will be used for working capital and provide funds for general corporate purposes.